Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00083421 · ClinicalTrials.gov registry record · Phase 2
Effects of ONO-2506PO in Patients With Alzheimer's Disease
A Phase 2 study, sponsored by Ono Pharma USA.
- Completed
- Registry status
- Phase 2
- Development phase
- 647
- Enrollment target
NCT00083421 is a Phase 2 study that has completed, run by Ono Pharma USA. The registered enrollment target is 647 participants.
The verdict
NCT00083421, a Phase 2 study, has completed, sponsored by Ono Pharma USA.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 647 participants
- Enrollment target
Study Summary
The purpose of this study is to establish the presence of an effect of treatment with ONO-2506PO in patients with Alzheimer's Disease, based upon cognitive and global scales.
Interventions
- DRUG ONO-2506PO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 647 participants |
| Start Date | 2004-06 |
| Est. Completion | 2007-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00083421
The ClinicalTrials.gov registry entry for NCT00083421 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 647 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ono Pharma USA, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ONO-2506PO is the first listed.
NCT00083421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00083421 about?
NCT00083421 is a clinical study titled "Effects of ONO-2506PO in Patients With Alzheimer's Disease". The purpose of this study is to establish the presence of an effect of treatment with ONO-2506PO in patients with Alzheimer's Disease, based upon cognitive and global scales.
What is the current status of trial NCT00083421?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 647 participants. The study started on 2004-06. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00083421?
The interventions under investigation include: ONO-2506PO (DRUG).
Who is sponsoring clinical trial NCT00083421?
This trial is sponsored by Ono Pharma USA, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.